Ana P Kiess

7PUBLICATIONS
71CO-AUTHORS
Radiation therapyProfessional ethicsPredictive and prognostic markersInstruments and techniquesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 03, 2025
Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights.

Phuoc T Tran, Jarey H Wang, Chad Tang

|May 30, 2025
Correction to: Guiding principles on the education and practice of theranostics.

Thomas N B Pascual, Diana Paez, Andrei Iagaru

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Jan 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews, Yohan Kim, Edlira Horjeti

|Mar 14, 2024
How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design.

Ana P Kiess, Joseph O'Donoghue, Carlos Uribe

Pageof 2